This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UK watchdog publishes key questions in Alliance Medical, IBA Molecular merger

( April 29, 2014, 10:37 GMT | Official Statement) -- MLex Summary: The UK’s Competition and Markets Authority has outlined the key questions in its review of Alliance Medical’s acquisition of medical-diagnosis assets from IBA Molecular. The target company makes a radioactive tracer used in cancer-diagnosis scans. Interested parties have until May 13 to submit comments. The regulator will publish its final report by Sept. 7.Tracer merger: issues statement...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login